Symbol:
RFTN1
Name:
raftlin, lipid raft linker 1
RGD ID:
1604380
HGNC Page
HGNC:30278
Description:
Enables double-stranded RNA binding activity. Involved in B cell receptor signaling pathway; membrane raft assembly; and positive regulation of growth rate. Acts upstream of or within dsRNA transport; response to exogenous dsRNA; and toll-like receptor 3 signaling pathway. Located in endosome; membrane raft; and plasma membrane. Part of protein-containing complex. Biomarker of glaucoma.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
cell migration-inducing gene 2 protein; FLJ23866; KIAA0084; MGC141678; MGC44480; MIG2; PIB10; PIG9; proliferation-inducing protein 10; proliferation-inducing protein 9; raft-linking protein; raftlin
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Mus musculus (house mouse):
Rftn1 (raftlin lipid raft linker 1)
HGNC
EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Rattus norvegicus (Norway rat):
Rftn1 (raftlin lipid raft linker 1)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Chinchilla lanigera (long-tailed chinchilla):
Rftn1 (raftlin, lipid raft linker 1)
NCBI
Ortholog
Pan paniscus (bonobo/pygmy chimpanzee):
RFTN1 (raftlin, lipid raft linker 1)
NCBI
Ortholog
Canis lupus familiaris (dog):
RFTN1 (raftlin, lipid raft linker 1)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Rftn1 (raftlin, lipid raft linker 1)
NCBI
Ortholog
Sus scrofa (pig):
RFTN1 (raftlin, lipid raft linker 1)
HGNC
EggNOG, Ensembl, NCBI, OrthoDB, Panther
Chlorocebus sabaeus (green monkey):
RFTN1 (raftlin, lipid raft linker 1)
NCBI
Ortholog
Heterocephalus glaber (naked mole-rat):
Rftn1 (raftlin, lipid raft linker 1)
NCBI
Ortholog
Alliance orthologs 3
Mus musculus (house mouse):
Rftn1 (raftlin lipid raft linker 1)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Rattus norvegicus (Norway rat):
Rftn1 (raftlin lipid raft linker 1)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
rftn1a (raftlin, lipid raft linker 1a)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|PANTHER|PhylomeDB|ZFIN)
Xenopus tropicalis (tropical clawed frog):
rftn1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus laevis (African clawed frog):
rftn1.L
Alliance
DIOPT (Xenbase)
Related Pseudogenes:
RFTN1P1
Allele / Splice:
See ClinVar data
Latest Assembly:
GRCh38 - Human Genome Assembly GRCh38
Position:
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 3 16,315,845 - 16,513,699 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 3 16,313,574 - 16,514,026 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 3 16,357,352 - 16,555,206 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 3 16,332,356 - 16,530,226 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 3 16,296,470 - 16,494,283 (-) NCBI Celera Cytogenetic Map 3 p24.3 NCBI HuRef 3 16,290,978 - 16,488,996 (-) NCBI HuRef CHM1_1 3 16,308,420 - 16,506,893 (-) NCBI CHM1_1 T2T-CHM13v2.0 3 16,317,057 - 16,514,836 (-) NCBI T2T-CHM13v2.0
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
RFTN1 Human (-)-demecolcine increases expression EXP 6480464 Demecolcine results in increased expression of RFTN1 mRNA CTD PMID:23649840 RFTN1 Human 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of RFTN1 mRNA CTD PMID:19619570 RFTN1 Human 17beta-estradiol multiple interactions ISO Rftn1 (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RFTN1 mRNA CTD PMID:32741896 RFTN1 Human 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of RFTN1 mRNA and [Estradiol co-treated with TGFB1 protein] results in increased expression of RFTN1 mRNA CTD PMID:19619570 and PMID:30165855 RFTN1 Human 17beta-estradiol 3-benzoate multiple interactions ISO Rftn1 (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RFTN1 mRNA CTD PMID:32741896 RFTN1 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of RFTN1 mRNA and Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to RFTN1 gene] CTD PMID:19619570 and PMID:28681081 RFTN1 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Rftn1 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of RFTN1 mRNA CTD PMID:33387578 RFTN1 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Rftn1 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of RFTN1 mRNA CTD PMID:34747641 RFTN1 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Rftn1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of RFTN1 mRNA CTD PMID:21570461 RFTN1 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of RFTN1 mRNA CTD PMID:19619570 RFTN1 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of RFTN1 mRNA CTD PMID:20106945 RFTN1 Human 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO Rftn1 (Rattus norvegicus) 6480464 2 more ... CTD PMID:32109520 RFTN1 Human 2,4,6-tribromophenol increases expression EXP 6480464 2 more ... CTD PMID:31675489 RFTN1 Human 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of RFTN1 protein CTD PMID:31675489 RFTN1 Human 4,4'-sulfonyldiphenol multiple interactions ISO Rftn1 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RFTN1 mRNA CTD PMID:36041667 RFTN1 Human 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of RFTN1 protein CTD PMID:34186270 RFTN1 Human 6-propyl-2-thiouracil increases expression ISO Rftn1 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of RFTN1 mRNA CTD PMID:24780913 RFTN1 Human acetamide increases expression ISO Rftn1 (Rattus norvegicus) 6480464 acetamide results in increased expression of RFTN1 mRNA CTD PMID:31881176 RFTN1 Human aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of RFTN1 mRNA CTD PMID:22100608 RFTN1 Human aflatoxin B1 decreases methylation EXP 6480464 Aflatoxin B1 results in decreased methylation of RFTN1 gene CTD PMID:27153756 RFTN1 Human all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of RFTN1 mRNA CTD PMID:21934132 RFTN1 Human all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of RFTN1 mRNA CTD PMID:23724009 and PMID:33167477 RFTN1 Human amphetamine decreases expression ISO Rftn1 (Rattus norvegicus) 6480464 Amphetamine results in decreased expression of RFTN1 mRNA CTD PMID:30779732 RFTN1 Human arsane multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RFTN1 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RFTN1 mRNA CTD PMID:32525701 and PMID:39836092 RFTN1 Human arsenic atom multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RFTN1 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RFTN1 mRNA CTD PMID:32525701 and PMID:39836092 RFTN1 Human benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of RFTN1 5' UTR CTD PMID:27901495 RFTN1 Human benzo[a]pyrene decreases methylation ISO Rftn1 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased methylation of RFTN1 intron CTD PMID:27901495 RFTN1 Human benzo[e]pyrene increases methylation EXP 6480464 benzo(e)pyrene results in increased methylation of RFTN1 intron CTD PMID:30157460 RFTN1 Human bisphenol A increases expression ISO Rftn1 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of RFTN1 mRNA CTD PMID:25181051 RFTN1 Human bisphenol A increases expression ISO Rftn1 (Mus musculus) 6480464 bisphenol A results in increased expression of RFTN1 mRNA CTD PMID:32156529 RFTN1 Human bisphenol A multiple interactions ISO Rftn1 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RFTN1 mRNA CTD PMID:36041667 RFTN1 Human bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of RFTN1 protein CTD PMID:34186270 RFTN1 Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of RFTN1 protein CTD PMID:31675489 RFTN1 Human bisphenol A decreases methylation EXP 6480464 bisphenol A results in decreased methylation of RFTN1 gene CTD PMID:31601247 RFTN1 Human bisphenol A decreases expression ISO Rftn1 (Mus musculus) 6480464 bisphenol A results in decreased expression of RFTN1 mRNA CTD PMID:30951980 RFTN1 Human bisphenol A decreases expression ISO Rftn1 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of RFTN1 mRNA CTD PMID:30816183 more ... RFTN1 Human bisphenol A increases methylation ISO Rftn1 (Rattus norvegicus) 6480464 bisphenol A results in increased methylation of RFTN1 gene CTD PMID:28505145 RFTN1 Human bisphenol AF increases expression EXP 6480464 bisphenol AF results in increased expression of RFTN1 protein CTD PMID:34186270 RFTN1 Human Bisphenol B increases expression EXP 6480464 bisphenol B results in increased expression of RFTN1 protein CTD PMID:34186270 RFTN1 Human bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of RFTN1 protein CTD PMID:34186270 RFTN1 Human bisphenol F multiple interactions ISO Rftn1 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RFTN1 mRNA CTD PMID:36041667 RFTN1 Human butan-1-ol multiple interactions EXP 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RFTN1 mRNA CTD PMID:29432896 RFTN1 Human C60 fullerene decreases expression ISO Rftn1 (Rattus norvegicus) 6480464 fullerene C60 results in decreased expression of RFTN1 mRNA CTD PMID:19167457 RFTN1 Human cantharidin decreases expression ISO Rftn1 (Mus musculus) 6480464 Cantharidin results in decreased expression of RFTN1 mRNA CTD PMID:36907384 RFTN1 Human carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of RFTN1 mRNA CTD PMID:25979313 RFTN1 Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to RFTN1 gene] CTD PMID:28238834 RFTN1 Human chloroethene increases expression ISO Rftn1 (Mus musculus) 6480464 Vinyl Chloride results in increased expression of RFTN1 mRNA CTD PMID:18579281 RFTN1 Human cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of RFTN1 mRNA CTD PMID:19561079 RFTN1 Human cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of RFTN1 mRNA CTD PMID:27392435 RFTN1 Human cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of RFTN1 mRNA CTD PMID:19320972 RFTN1 Human copper atom multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in increased expression of RFTN1 mRNA CTD PMID:24690739 RFTN1 Human copper(0) multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in increased expression of RFTN1 mRNA CTD PMID:24690739 RFTN1 Human copper(II) chloride increases expression EXP 6480464 cupric chloride results in increased expression of RFTN1 mRNA CTD PMID:38568856 RFTN1 Human coumestrol multiple interactions EXP 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RFTN1 mRNA CTD PMID:19167446 RFTN1 Human coumestrol decreases expression EXP 6480464 Coumestrol results in decreased expression of RFTN1 mRNA CTD PMID:19167446 RFTN1 Human crocidolite asbestos decreases expression ISO Rftn1 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of RFTN1 mRNA CTD PMID:29279043 RFTN1 Human Cuprizon increases expression ISO Rftn1 (Rattus norvegicus) 6480464 Cuprizone results in increased expression of RFTN1 mRNA CTD PMID:26577399 RFTN1 Human cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of RFTN1 mRNA CTD PMID:20106945 RFTN1 Human DDT decreases methylation ISO Rftn1 (Rattus norvegicus) 6480464 DDT results in decreased methylation of RFTN1 gene CTD PMID:30207508 RFTN1 Human Dibutyl phosphate affects expression EXP 6480464 di-n-butylphosphoric acid affects the expression of RFTN1 mRNA CTD PMID:37042841 RFTN1 Human disulfiram multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in increased expression of RFTN1 mRNA CTD PMID:24690739 RFTN1 Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 RFTN1 Human doxorubicin affects response to substance EXP 6480464 RFTN1 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 RFTN1 Human elemental selenium increases expression EXP 6480464 Selenium results in increased expression of RFTN1 mRNA CTD PMID:19244175 RFTN1 Human Enterolactone multiple interactions EXP 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RFTN1 mRNA CTD PMID:19167446 RFTN1 Human fonofos increases methylation EXP 6480464 Fonofos results in increased methylation of RFTN1 promoter CTD PMID:22847954 RFTN1 Human formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of RFTN1 mRNA CTD PMID:23649840 RFTN1 Human FR900359 decreases phosphorylation EXP 6480464 FR900359 results in decreased phosphorylation of RFTN1 protein CTD PMID:37730182 RFTN1 Human gentamycin increases expression ISO Rftn1 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of RFTN1 mRNA CTD PMID:22061828 RFTN1 Human glyphosate increases expression ISO Rftn1 (Mus musculus) 6480464 Glyphosate results in increased expression of RFTN1 mRNA CTD PMID:35897073 RFTN1 Human hydrogen peroxide multiple interactions EXP 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of RFTN1 protein CTD PMID:18951874 RFTN1 Human hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of RFTN1 mRNA CTD PMID:18951874 RFTN1 Human hydroquinone increases expression EXP 6480464 hydroquinone results in increased expression of RFTN1 mRNA CTD PMID:31256213 RFTN1 Human inulin multiple interactions ISO Rftn1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RFTN1 mRNA CTD PMID:36331819 RFTN1 Human ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of RFTN1 protein CTD PMID:32959892 RFTN1 Human lead(0) affects expression EXP 6480464 Lead affects the expression of RFTN1 mRNA CTD PMID:28903495 RFTN1 Human lipopolysaccharide multiple interactions EXP 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RFTN1 mRNA CTD PMID:35811015 RFTN1 Human lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of RFTN1 mRNA CTD PMID:35811015 RFTN1 Human methapyrilene increases methylation EXP 6480464 Methapyrilene results in increased methylation of RFTN1 intron CTD PMID:30157460 RFTN1 Human methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of RFTN1 mRNA CTD PMID:24449571 RFTN1 Human methoxychlor affects methylation ISO Rftn1 (Rattus norvegicus) 6480464 Methoxychlor affects the methylation of RFTN1 gene CTD PMID:35440735 RFTN1 Human methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of RFTN1 mRNA CTD PMID:28001369 RFTN1 Human N,N-diethyl-m-toluamide multiple interactions ISO Rftn1 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in decreased methylation of RFTN1 gene CTD PMID:33148267 RFTN1 Human nitrates multiple interactions ISO Rftn1 (Mus musculus) 6480464 [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RFTN1 mRNA CTD PMID:35964746 RFTN1 Human O-methyleugenol decreases expression EXP 6480464 methyleugenol results in decreased expression of RFTN1 mRNA CTD PMID:32234424 RFTN1 Human oxaliplatin multiple interactions ISO Rftn1 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of RFTN1 mRNA CTD PMID:25729387 RFTN1 Human ozone multiple interactions ISO Rftn1 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of RFTN1 mRNA more ... CTD PMID:27106289 and PMID:34911549 RFTN1 Human paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of RFTN1 mRNA CTD PMID:21420995 RFTN1 Human parathion increases methylation EXP 6480464 Parathion results in increased methylation of RFTN1 promoter CTD PMID:22847954 RFTN1 Human perfluorohexanesulfonic acid decreases expression ISO Rftn1 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in decreased expression of RFTN1 mRNA CTD PMID:37995155 RFTN1 Human perfluorononanoic acid decreases expression EXP 6480464 perfluoro-n-nonanoic acid results in decreased expression of RFTN1 mRNA CTD PMID:32588087 RFTN1 Human perfluorooctane-1-sulfonic acid multiple interactions ISO Rftn1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RFTN1 mRNA CTD PMID:36331819 RFTN1 Human permethrin multiple interactions ISO Rftn1 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in decreased methylation of RFTN1 gene CTD PMID:33148267 RFTN1 Human phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RFTN1 mRNA CTD PMID:27188386 RFTN1 Human raloxifene multiple interactions EXP 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of RFTN1 mRNA CTD PMID:19059307 RFTN1 Human resveratrol increases expression EXP 6480464 resveratrol results in increased expression of RFTN1 mRNA CTD PMID:25888808 RFTN1 Human S-(1,2-dichlorovinyl)-L-cysteine multiple interactions EXP 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RFTN1 mRNA CTD PMID:35811015 RFTN1 Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 RFTN1 Human selenium atom increases expression EXP 6480464 Selenium results in increased expression of RFTN1 mRNA CTD PMID:19244175 RFTN1 Human sodium arsenate multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RFTN1 mRNA CTD PMID:32525701 RFTN1 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of RFTN1 mRNA CTD PMID:38568856 RFTN1 Human sodium arsenite multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RFTN1 mRNA CTD PMID:39836092 RFTN1 Human sodium arsenite increases expression ISO Rftn1 (Mus musculus) 6480464 sodium arsenite results in increased expression of RFTN1 mRNA CTD PMID:37682722 RFTN1 Human sunitinib increases expression EXP 6480464 Sunitinib results in increased expression of RFTN1 mRNA CTD PMID:31533062 RFTN1 Human tamoxifen multiple interactions EXP 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of RFTN1 mRNA CTD PMID:19059307 RFTN1 Human tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of RFTN1 mRNA CTD PMID:14699072 RFTN1 Human temozolomide decreases expression EXP 6480464 Temozolomide results in decreased expression of RFTN1 mRNA CTD PMID:31758290 RFTN1 Human terbufos increases methylation EXP 6480464 terbufos results in increased methylation of RFTN1 promoter CTD PMID:22847954 RFTN1 Human testosterone multiple interactions ISO Rftn1 (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RFTN1 mRNA CTD PMID:32741896 RFTN1 Human tetrachloromethane affects expression ISO Rftn1 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of RFTN1 mRNA CTD PMID:17484886 RFTN1 Human thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of RFTN1 mRNA CTD PMID:22378314 RFTN1 Human theophylline multiple interactions EXP 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of RFTN1 protein CTD PMID:18951874 RFTN1 Human thioacetamide increases expression ISO Rftn1 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of RFTN1 mRNA CTD PMID:34492290 RFTN1 Human thiram increases expression EXP 6480464 Thiram results in increased expression of RFTN1 mRNA CTD PMID:38568856 RFTN1 Human titanium dioxide decreases methylation ISO Rftn1 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of RFTN1 gene CTD PMID:35295148 RFTN1 Human topotecan multiple interactions ISO Rftn1 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of RFTN1 mRNA CTD PMID:25729387 RFTN1 Human topotecan affects response to substance EXP 6480464 RFTN1 protein affects the susceptibility to Topotecan CTD PMID:16217747 RFTN1 Human trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of RFTN1 mRNA CTD PMID:24935251 RFTN1 Human trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of RFTN1 mRNA CTD PMID:24935251 RFTN1 Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of RFTN1 mRNA CTD PMID:37042841 RFTN1 Human troglitazone decreases expression ISO Rftn1 (Mus musculus) 6480464 troglitazone results in decreased expression of RFTN1 mRNA CTD PMID:28973697 RFTN1 Human urethane decreases expression EXP 6480464 Urethane results in decreased expression of RFTN1 mRNA CTD PMID:28818685 RFTN1 Human valproic acid decreases methylation EXP 6480464 Valproic Acid results in decreased methylation of RFTN1 gene CTD PMID:29154799 RFTN1 Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of RFTN1 mRNA CTD PMID:19101580 more ... RFTN1 Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of RFTN1 mRNA CTD PMID:25979313 RFTN1 Human valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RFTN1 mRNA CTD PMID:27188386 RFTN1 Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of RFTN1 mRNA CTD PMID:23179753 more ... RFTN1 Human vincristine increases expression EXP 6480464 Vincristine results in increased expression of RFTN1 mRNA CTD PMID:23649840 RFTN1 Human vitamin E increases expression EXP 6480464 Vitamin E results in increased expression of RFTN1 mRNA CTD PMID:19244175
(-)-demecolcine (EXP) 17beta-estradiol (EXP,ISO) 17beta-estradiol 3-benzoate (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,3,7,8-Tetrachlorodibenzofuran (ISO) 2,4,6-tribromophenol (EXP) 3,3',5,5'-tetrabromobisphenol A (EXP) 4,4'-sulfonyldiphenol (EXP,ISO) 6-propyl-2-thiouracil (ISO) acetamide (ISO) aflatoxin B1 (EXP) all-trans-retinoic acid (EXP) amphetamine (ISO) arsane (EXP) arsenic atom (EXP) benzo[a]pyrene (EXP,ISO) benzo[e]pyrene (EXP) bisphenol A (EXP,ISO) bisphenol AF (EXP) Bisphenol B (EXP) bisphenol F (EXP,ISO) butan-1-ol (EXP) C60 fullerene (ISO) cantharidin (ISO) carbamazepine (EXP) CGP 52608 (EXP) chloroethene (ISO) cisplatin (EXP) cobalt dichloride (EXP) copper atom (EXP) copper(0) (EXP) copper(II) chloride (EXP) coumestrol (EXP) crocidolite asbestos (ISO) Cuprizon (ISO) cyclosporin A (EXP) DDT (ISO) Dibutyl phosphate (EXP) disulfiram (EXP) dorsomorphin (EXP) doxorubicin (EXP) elemental selenium (EXP) Enterolactone (EXP) fonofos (EXP) formaldehyde (EXP) FR900359 (EXP) gentamycin (ISO) glyphosate (ISO) hydrogen peroxide (EXP) hydroquinone (EXP) inulin (ISO) ivermectin (EXP) lead(0) (EXP) lipopolysaccharide (EXP) methapyrilene (EXP) methotrexate (EXP) methoxychlor (ISO) methylmercury chloride (EXP) N,N-diethyl-m-toluamide (ISO) nitrates (ISO) O-methyleugenol (EXP) oxaliplatin (ISO) ozone (ISO) paracetamol (EXP) parathion (EXP) perfluorohexanesulfonic acid (ISO) perfluorononanoic acid (EXP) perfluorooctane-1-sulfonic acid (ISO) permethrin (ISO) phenylmercury acetate (EXP) raloxifene (EXP) resveratrol (EXP) S-(1,2-dichlorovinyl)-L-cysteine (EXP) SB 431542 (EXP) selenium atom (EXP) sodium arsenate (EXP) sodium arsenite (EXP,ISO) sunitinib (EXP) tamoxifen (EXP) temozolomide (EXP) terbufos (EXP) testosterone (ISO) tetrachloromethane (ISO) thapsigargin (EXP) theophylline (EXP) thioacetamide (ISO) thiram (EXP) titanium dioxide (ISO) topotecan (EXP,ISO) trichostatin A (EXP) triphenyl phosphate (EXP) troglitazone (ISO) urethane (EXP) valproic acid (EXP) vincristine (EXP) vitamin E (EXP)
RFTN1 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 3 16,315,845 - 16,513,699 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 3 16,313,574 - 16,514,026 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 3 16,357,352 - 16,555,206 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 3 16,332,356 - 16,530,226 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 3 16,296,470 - 16,494,283 (-) NCBI Celera Cytogenetic Map 3 p24.3 NCBI HuRef 3 16,290,978 - 16,488,996 (-) NCBI HuRef CHM1_1 3 16,308,420 - 16,506,893 (-) NCBI CHM1_1 T2T-CHM13v2.0 3 16,317,057 - 16,514,836 (-) NCBI T2T-CHM13v2.0
Rftn1 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 17 50,300,287 - 50,497,525 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 17 50,299,285 - 50,497,702 (-) Ensembl GRCm39 Ensembl GRCm38 17 49,993,258 - 50,190,497 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 17 49,992,257 - 50,190,674 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 17 50,132,632 - 50,329,822 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 17 49,458,874 - 49,656,064 (-) NCBI MGSCv36 mm8 Celera 17 53,430,090 - 53,626,629 (-) NCBI Celera Cytogenetic Map 17 C NCBI cM Map 17 25.86 NCBI
Rftn1 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 9 18,302,143 - 18,499,819 (+) NCBI GRCr8 mRatBN7.2 9 10,804,611 - 11,002,084 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 9 10,804,611 - 11,002,084 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 9 19,306,013 - 19,502,552 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 9 24,372,610 - 24,569,138 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 9 22,754,195 - 22,950,721 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 9 12,740,885 - 12,942,358 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 9 12,740,885 - 12,942,358 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 9 11,679,882 - 11,880,237 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 9 6,008,948 - 6,207,477 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 9 8,582,887 - 8,778,558 (+) NCBI Celera Cytogenetic Map 9 q12 NCBI
Rftn1 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955430 8,603,401 - 8,779,896 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955430 8,605,057 - 8,801,187 (-) NCBI ChiLan1.0 ChiLan1.0
RFTN1 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 2 16,301,250 - 16,500,922 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 3 16,306,013 - 16,505,411 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 3 16,241,255 - 16,441,402 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 3 16,578,092 - 16,778,464 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 3 16,578,092 - 16,778,464 (-) Ensembl panpan1.1 panPan2
RFTN1 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 23 26,272,103 - 26,472,610 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 23 26,282,392 - 26,472,536 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 23 26,247,350 - 26,447,817 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 23 26,773,327 - 26,973,915 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 23 26,773,112 - 26,973,909 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 23 26,474,319 - 26,674,595 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 23 26,535,808 - 26,736,282 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 23 26,784,871 - 26,985,542 (+) NCBI UU_Cfam_GSD_1.0
Rftn1 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405118 175,980,661 - 176,179,125 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936473 9,117,247 - 9,317,704 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936473 9,119,234 - 9,317,696 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
RFTN1 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 13 3,454,454 - 3,674,998 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 13 3,454,448 - 3,675,072 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 13 3,744,156 - 3,861,922 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
RFTN1 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 15 61,159,573 - 61,290,342 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 15 61,159,930 - 61,289,965 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666041 34,169,257 - 34,371,665 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Rftn1 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 2839 Count of miRNA genes: 929 Interacting mature miRNAs: 1102 Transcripts: ENST00000334133, ENST00000431547, ENST00000432519, ENST00000441460, ENST00000449415, ENST00000451036, ENST00000453536, ENST00000470458, ENST00000483671, ENST00000484752, ENST00000495666, ENST00000607320 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
597144662 GWAS1240736_H COVID-19 QTL GWAS1240736 (human) 4e-13 COVID-19 3 16398091 16398092 Human 407128006 GWAS776982_H obesity QTL GWAS776982 (human) 0.000005 obesity 3 16366982 16366983 Human 597332600 GWAS1428674_H S-warfarin measurement QTL GWAS1428674 (human) 0.000004 S-warfarin measurement 3 16466863 16466864 Human 597424893 GWAS1520967_H thoracic aortic aneurysm QTL GWAS1520967 (human) 0.0000008 thoracic aortic aneurysm 3 16322022 16322023 Human 597144465 GWAS1240539_H COVID-19 QTL GWAS1240539 (human) 0.000009 COVID-19 3 16399921 16399922 Human 597336124 GWAS1432198_H language measurement QTL GWAS1432198 (human) 0.000005 language measurement 3 16466672 16466673 Human 597198708 GWAS1294782_H systolic blood pressure QTL GWAS1294782 (human) 8e-10 systolic blood pressure systolic blood pressure (CMO:0000004) 3 16322182 16322183 Human 597146075 GWAS1242149_H COVID-19 QTL GWAS1242149 (human) 0.000004 COVID-19 3 16403074 16403075 Human 597140058 GWAS1236132_H COVID-19 QTL GWAS1236132 (human) 2e-08 COVID-19 3 16398099 16398100 Human 597135001 GWAS1231075_H diastolic blood pressure QTL GWAS1231075 (human) 1e-08 diastolic blood pressure diastolic blood pressure (CMO:0000005) 3 16322182 16322183 Human 407039539 GWAS688515_H urate measurement, body mass index QTL GWAS688515 (human) 0.000006 urate measurement, body mass index body mass index (BMI) (CMO:0000105) 3 16376048 16376049 Human 597145061 GWAS1241135_H COVID-19 QTL GWAS1241135 (human) 0.0000002 COVID-19 3 16412973 16412974 Human 597328578 GWAS1424652_H response to antibiotic, hematological measurement QTL GWAS1424652 (human) 4e-08 response to antibiotic, hematological measurement blood measurement (CMO:0000035) 3 16509706 16509707 Human 2316345 GLUCO224_H Glucose level QTL 224 (human) 1.27 0.008 Glucose level 3 1 21543441 Human 597176610 GWAS1272684_H fumarate measurement QTL GWAS1272684 (human) 3e-08 fumarate measurement 3 16416516 16416517 Human 597144330 GWAS1240404_H COVID-19 QTL GWAS1240404 (human) 0.0000003 COVID-19 3 16405919 16405920 Human
D3S3473
Human Assembly Chr Position (strand) Source JBrowse GRCh37 3 16,522,348 - 16,522,566 UniSTS GRCh37 Build 36 3 16,497,352 - 16,497,570 RGD NCBI36 Celera 3 16,461,411 - 16,461,629 RGD Cytogenetic Map 3 p24.3 UniSTS HuRef 3 16,456,119 - 16,456,337 UniSTS Marshfield Genetic Map 3 42.1 RGD Marshfield Genetic Map 3 42.1 UniSTS Genethon Genetic Map 3 35.8 UniSTS deCODE Assembly Map 3 36.69 UniSTS Stanford-G3 RH Map 3 794.0 UniSTS Whitehead-YAC Contig Map 3 UniSTS NCBI RH Map 3 185.3 UniSTS GeneMap99-G3 RH Map 3 794.0 UniSTS
RH12058
Human Assembly Chr Position (strand) Source JBrowse GRCh37 3 16,357,416 - 16,357,580 UniSTS GRCh37 Build 36 3 16,332,420 - 16,332,584 RGD NCBI36 Celera 3 16,296,534 - 16,296,698 RGD Cytogenetic Map 3 p24.3 UniSTS HuRef 3 16,291,042 - 16,291,206 UniSTS GeneMap99-GB4 RH Map 3 69.58 UniSTS NCBI RH Map 3 192.6 UniSTS
RH35828
Human Assembly Chr Position (strand) Source JBrowse GRCh37 3 16,502,627 - 16,502,800 UniSTS GRCh37 Build 36 3 16,477,631 - 16,477,804 RGD NCBI36 Celera 3 16,441,690 - 16,441,863 RGD Cytogenetic Map 3 p24.3 UniSTS HuRef 3 16,436,396 - 16,436,569 UniSTS GeneMap99-GB4 RH Map 3 68.65 UniSTS
RH92877
Human Assembly Chr Position (strand) Source JBrowse GRCh37 3 16,381,082 - 16,381,205 UniSTS GRCh37 Build 36 3 16,356,086 - 16,356,209 RGD NCBI36 Celera 3 16,320,200 - 16,320,323 RGD Cytogenetic Map 3 p24.3 UniSTS HuRef 3 16,314,708 - 16,314,831 UniSTS GeneMap99-GB4 RH Map 3 69.79 UniSTS
SHGC-58196
Human Assembly Chr Position (strand) Source JBrowse GRCh37 3 16,433,448 - 16,433,666 UniSTS GRCh37 Build 36 3 16,408,452 - 16,408,670 RGD NCBI36 Celera 3 16,372,558 - 16,372,776 RGD Cytogenetic Map 3 p24.3 UniSTS HuRef 3 16,367,016 - 16,367,234 UniSTS TNG Radiation Hybrid Map 3 9787.0 UniSTS
SHGC-79918
Human Assembly Chr Position (strand) Source JBrowse GRCh37 3 16,392,438 - 16,392,729 UniSTS GRCh37 Build 36 3 16,367,442 - 16,367,733 RGD NCBI36 Celera 3 16,331,550 - 16,331,841 RGD Cytogenetic Map 3 p24.3 UniSTS HuRef 3 16,326,036 - 16,326,327 UniSTS TNG Radiation Hybrid Map 3 9774.0 UniSTS
SHGC-86345
Human Assembly Chr Position (strand) Source JBrowse GRCh37 3 16,465,327 - 16,465,599 UniSTS GRCh37 Build 36 3 16,440,331 - 16,440,603 RGD NCBI36 Celera 3 16,404,389 - 16,404,661 RGD Cytogenetic Map 3 p24.3 UniSTS HuRef 3 16,399,081 - 16,399,353 UniSTS
SHGC-83722
Human Assembly Chr Position (strand) Source JBrowse GRCh37 3 16,513,475 - 16,513,816 UniSTS GRCh37 Build 36 3 16,488,479 - 16,488,820 RGD NCBI36 Celera 3 16,452,538 - 16,452,879 RGD Cytogenetic Map 3 p24.3 UniSTS HuRef 3 16,447,246 - 16,447,587 UniSTS TNG Radiation Hybrid Map 3 9820.0 UniSTS
G62938
Human Assembly Chr Position (strand) Source JBrowse GRCh37 3 16,440,735 - 16,441,007 UniSTS GRCh37 Build 36 3 16,415,739 - 16,416,011 RGD NCBI36 Celera 3 16,379,840 - 16,380,112 RGD Cytogenetic Map 3 p24.3 UniSTS HuRef 3 16,374,273 - 16,374,545 UniSTS TNG Radiation Hybrid Map 3 9791.0 UniSTS
SHGC-105736
Human Assembly Chr Position (strand) Source JBrowse GRCh37 3 16,460,471 - 16,460,574 UniSTS GRCh37 Build 36 3 16,435,475 - 16,435,578 RGD NCBI36 Celera 3 16,399,533 - 16,399,636 RGD Cytogenetic Map 3 p24.3 UniSTS HuRef 3 16,394,225 - 16,394,328 UniSTS
SHGC-150983
Human Assembly Chr Position (strand) Source JBrowse GRCh37 3 16,522,292 - 16,522,563 UniSTS GRCh37 Build 36 3 16,497,296 - 16,497,567 RGD NCBI36 Celera 3 16,461,355 - 16,461,626 RGD Cytogenetic Map 3 p24.3 UniSTS HuRef 3 16,456,063 - 16,456,334 UniSTS TNG Radiation Hybrid Map 3 9825.0 UniSTS TNG Radiation Hybrid Map 10 60179.0 UniSTS
RAFTLIN_9316
Human Assembly Chr Position (strand) Source JBrowse GRCh37 3 16,357,326 - 16,358,130 UniSTS GRCh37 Build 36 3 16,332,330 - 16,333,134 RGD NCBI36 Celera 3 16,296,444 - 16,297,248 RGD HuRef 3 16,290,952 - 16,291,756 UniSTS
RH25312
Human Assembly Chr Position (strand) Source JBrowse GRCh37 3 16,357,395 - 16,357,529 UniSTS GRCh37 Build 36 3 16,332,399 - 16,332,533 RGD NCBI36 Celera 3 16,296,513 - 16,296,647 RGD Cytogenetic Map 3 p24.3 UniSTS HuRef 3 16,291,021 - 16,291,155 UniSTS GeneMap99-GB4 RH Map 3 69.25 UniSTS NCBI RH Map 3 190.5 UniSTS
UniSTS:31995
Human Assembly Chr Position (strand) Source JBrowse GRCh37 3 16,366,048 - 16,366,237 UniSTS GRCh37 GRCh37 10 109,383,977 - 109,384,122 UniSTS GRCh37 Build 36 3 16,341,052 - 16,341,241 RGD NCBI36 Celera 3 16,305,166 - 16,305,355 RGD Celera 10 103,123,098 - 103,123,243 UniSTS HuRef 3 165,771,634 - 165,771,780 UniSTS HuRef 3 16,299,674 - 16,299,863 UniSTS HuRef 10 103,016,425 - 103,016,570 UniSTS
D3S3885
Human Assembly Chr Position (strand) Source JBrowse GRCh37 3 16,358,078 - 16,358,224 UniSTS GRCh37 Build 36 3 16,333,082 - 16,333,228 RGD NCBI36 Celera 3 16,297,196 - 16,297,342 RGD Cytogenetic Map 3 p24.3 UniSTS HuRef 3 16,291,704 - 16,291,850 UniSTS Stanford-G3 RH Map 3 787.0 UniSTS Whitehead-YAC Contig Map 3 UniSTS NCBI RH Map 3 184.9 UniSTS GeneMap99-G3 RH Map 3 787.0 UniSTS
RH78558
Human Assembly Chr Position (strand) Source JBrowse GRCh37 3 16,424,660 - 16,424,800 UniSTS GRCh37 Build 36 3 16,399,664 - 16,399,804 RGD NCBI36 Celera 3 16,363,773 - 16,363,913 RGD Cytogenetic Map 3 p24.3 UniSTS HuRef 3 16,358,232 - 16,358,372 UniSTS GeneMap99-GB4 RH Map 3 68.38 UniSTS
SHGC-76751
Human Assembly Chr Position (strand) Source JBrowse GRCh37 3 16,377,702 - 16,377,869 UniSTS GRCh37 Build 36 3 16,352,706 - 16,352,873 RGD NCBI36 Celera 3 16,316,820 - 16,316,987 RGD Cytogenetic Map 3 p24.3 UniSTS HuRef 3 16,311,328 - 16,311,495 UniSTS TNG Radiation Hybrid Map 3 9774.0 UniSTS GeneMap99-GB4 RH Map 3 68.65 UniSTS NCBI RH Map 3 192.9 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
entire extraembryonic component
1204
2406
2788
2252
4965
1723
2344
4
622
1951
464
2269
7272
6467
47
3725
1
852
1739
1611
174
1
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENST00000334133 ⟹ ENSP00000334153
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 3 16,315,845 - 16,513,699 (-) Ensembl
Ensembl Acc Id:
ENST00000431547 ⟹ ENSP00000393216
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 3 16,409,473 - 16,514,026 (-) Ensembl
Ensembl Acc Id:
ENST00000432519 ⟹ ENSP00000403926
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 3 16,315,845 - 16,482,865 (-) Ensembl
Ensembl Acc Id:
ENST00000441460 ⟹ ENSP00000388718
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 3 16,378,095 - 16,512,922 (-) Ensembl
Ensembl Acc Id:
ENST00000449415 ⟹ ENSP00000409427
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 3 16,378,095 - 16,512,904 (-) Ensembl
Ensembl Acc Id:
ENST00000451036 ⟹ ENSP00000403997
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 3 16,377,719 - 16,513,374 (-) Ensembl
Ensembl Acc Id:
ENST00000453536 ⟹ ENSP00000410493
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 3 16,409,428 - 16,513,522 (-) Ensembl
Ensembl Acc Id:
ENST00000470458
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 3 16,378,072 - 16,472,599 (-) Ensembl
Ensembl Acc Id:
ENST00000483671
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 3 16,316,530 - 16,370,966 (-) Ensembl
Ensembl Acc Id:
ENST00000484752
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 3 16,378,053 - 16,484,835 (-) Ensembl
Ensembl Acc Id:
ENST00000495666
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 3 16,377,893 - 16,434,770 (-) Ensembl
Ensembl Acc Id:
ENST00000607320 ⟹ ENSP00000475367
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 3 16,313,574 - 16,326,867 (-) Ensembl
RefSeq Acc Id:
NM_015150 ⟹ NP_055965
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 3 16,315,845 - 16,513,699 (-) NCBI GRCh37 3 16,357,352 - 16,555,222 (-) RGD Build 36 3 16,332,356 - 16,530,226 (-) NCBI Archive Celera 3 16,296,470 - 16,494,283 (-) RGD HuRef 3 16,290,978 - 16,488,996 (-) ENTREZGENE CHM1_1 3 16,308,420 - 16,506,893 (-) NCBI T2T-CHM13v2.0 3 16,317,057 - 16,514,836 (-) NCBI
Sequence:
GCTGGAGCCGGAGCGCGCCGGGCGCTGGGCGCAGCGAGCGAGAGCGCGGCGGCCGCGGGCTCCGGCGAGGGACAGACGCACCGATCGCCGGAGGGACAGACACACGACCACGCGGCGCCACCGCCCAC GCCTCCACCCACCGGCGCCCAAGTCCTCCCCGCGCCGCCTCCTCTGTATGGCACAAACTTTCCTCCCGGGACGGAACACGCTGCCTCAGGGAGCCCGCGACCGCGCCTTCTCCTCCGCCGGTCCCATA CGCTGCTGAAATGGGTTGCGGATTGAACAAGTTAGAGAAACGTGATGAAAAACGGCCTGGGAATATTTATTCAACTTTGAAGAGGCCTCAGGTGGAAACCAAGATAGATGTGTCCTATGAATACCGCT TCCTGGAGTTCACGACTCTGAGTGCTGCGGAGCTCCCTGGGTCCTCAGCAGTGAGGCTGGCCTCCCTGCGTGACCTGCCCGCCCAGCTCCTGGAGCTGTACCAGCAGGGCTTCTCGCTGGCGGCCCTG CACCCCTTCGTGCAGCCCACCCATGAGCGGGAGAAGACGCCCCTGGAGCACATCTTTAGAGCCATCCTGATCAAGAAAACCGACAGATCTCAGAAAACTGATCTTCACAATGAAGGCTACATCTTGGA ATTAGATTGCTGTTCCTCCTTAGACCACCCGACAGACCAGAAACTCATCCCAGAGTTCATTAAGAAGATCCAGGAGGCTGCAAGCCAGGGCCTGAAATTCGTTGGTGTTATACCTCAGTACCATTCCT CTGTGAACTCGGCAGGCAGCAGTGCTCCGGTGTCTACTGCCAACAGCACCGAGGATGCCAGAGATGCAAAAAACGCACGTGGGGATCACGCGTCACTGGAGAATGAGAAACCGGGGACTGGGGATGTG TGCAGTGCTCCGGCTGGGAGAAACCAAAGCCCAGAGCCCAGCTCAGGCCCCAGAGGGGAGGTGCCCCTCGCCAAGCAGCCCAGCTCACCCTCCGGAGAGGGAGATGGTGGAGAACTTTCACCACAGGG GGTGAGCAAGACACTGGATGGACCGGAGAGCAACCCCTTGGAGGTGCATGAAGAGCCACTCTCAGGGAAAATGGAGATCTTCACCCTTTTCAACAAACCGAAGAGCCATCAGAAGTGCCGGCAATACT ACCCTGTCACCATTCCTCTCCATGTCTCCAAGAATGGCCAGACAGTGAGCGGTTTGGACGCCAACTGGTTAGAGCACATGAGCGACCACTTCCGGAAAGGAGGCATGCTGGTGAACGCAGTCTTCTAC CTTGGAATAGTGAATGATTCCTTACATGGCTTGACAGATGGAGTATTCATCTTTGAAGCTGTTTCCACAGAAGATAGCAAAACCATACAGGGCTATGATGCTATTGTGGTTGAACAATGGACAGTCCT GGAAGGTGTCGAAGTGCAGACAGACTACGTGCCCCTGCTGAACTCGCTGGCGGCCTATGGCTGGCAGCTCACCTGTGTGCTACCAACTCCCGTCGTCAAGACTACCAGCGAGGGGAGTGTATCCACCA AGCAGATTGTCTTTCTTCAGAGACCTTGTCTACCTCAGAAAATCAAGAAGAAGGAATCGAAGTTTCAGTGGCGATTCTCCAGAGAAGAAATGCACAACAGGCAGATGAGGAAATCAAAAGGTAAACTC AGTGCCAGAGACAAACAACAAGCAGAAGAAAATGAGAAGAACTTAGAAGACCAGTCTTCCAAAGCTGGAGACATGGGAAACTGTGTTTCAGGACAGCAGCAGGAGGGTGGAGTCTCCGAGGAGATGAA GGGCCCTGTCCAAGAGGACAAGGGAGAACAGCTGTCCCCTGGTGGCCTGCTGTGTGGGGTGGGTGTGGAGGGTGAGGCTGTGCAGAATGGTCCTGCCAGCCACAGCAGGGCCCTGGTGGGGATTTGCA CTGGGCACTCCAATCCTGGAGAGGATGCCAGGGACGGGGATGCTGAGGAAGTCAGAGAGCTTGGTACGGTTGAAGAAAACTGAGTCTTGGGCAATTTGTGCTAAAACTAGGTGAGTTGCCAAACCCAA GGCATCTTACCAACAGCTGGTTTGGGGGCTGGTTTCCCTGGTGTTGTGTGTTACCTACCCTTTGGCTTGGCTTGACCTCTCCTTGTGAGCTCACCTGAGCCCTCCCAGGGCCAGGTTCCTGACAGTGT TGGTTTTTGCACATCCACTGGAAAGGTGTCATTAATGACCCAGTGTTAGAATGCAAGAGGTCAGGTTATTCTAGCCCTCATGGCTGAAGGCCCAGTCCTGGCTCCACCACTCCTCCAGCCAGAGGGTC TGGACCATCCAGTGCCTGTCCTCGCCACAGGGCCTCCAGGGAGCATTCGGGTCAAATCCATGGACACCCTGGGCTACAAACCAAGGCTGCTGTTCATCCCACATCGTGTGGGGCAGTGTCCATCCCCT GCAGCTACTTGGTGACTTAACAACTCCAGGAGCCCTGTCAGCTGCCCTCCTCCACCTAAACCCCTTCGACTCTTCTGCTTTGACAAAGAAAATGACATTGGGGAGGGGAGGTGCTCCGCCTCCCAGCT TTTCTCAAAATAGTCCTATAGATACTGGTAATCTGGAAATGAAGAAGTAATTCTGTCTCTGCACCTACTTTTGCAGAATGTTCAAGGAAGTATTCTGTGTTAGTATTAATGCCAAAAAGTTGTTTTTA AAGGTTTTGTACTCAGCACATCATACAAACCACATTACTTCTGTCACTTCAGGGCATCGGGACTGGCTGGCGCCCTTGTTATGTGCTATTTTAATCAGTGTAACATTGGTCAAGTTGTTACCCATGTA TGCTGTGTTTATCATGTGTATATCGTCCAGAAAGTATTAAGGCTTTAGGTAGATGCAACTGGCGAACCTTGGAGAGGGAATGCTGATTGTCTTGACCAAACCCACAGCCTGTCTCTTCTCTTGTTTAG TTACTTACGGCAATAAATCATCTATGAGTTAGTGCACCGTGA
hide sequence
RefSeq Acc Id:
XM_005264985 ⟹ XP_005265042
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 3 16,315,845 - 16,513,699 (-) NCBI GRCh37 3 16,357,352 - 16,555,222 (-) NCBI
Sequence:
GCAGCGAGCGAGAGCGCGGCGGCCGCGGGCTCCGGCGAGGGACAGACGCACCGATCGCCGGAGG GACAGACACACGACCACGCGGCGCCACCGCCCACGCCTCCACCCACCGGCGCCCAAGTCCTCCCCGCGCCGCCTCCTCTGTATGGCACAAACTTTCCTCCCGGGACGGAACACGCTGCCTCAGGGAGC CCGCGACCGCGCCTTCTCCTCCGCCGGTCCCATACGCAGCTGCTGAAATGGGTTGCGGATTGAACAAGTTAGAGAAACGTGATGAAAAACGGCCTGGGAATATTTATTCAACTTTGAAGAGGCCTCAG GTGGAAACCAAGATAGATGTGTCCTATGAATACCGCTTCCTGGAGTTCACGACTCTGAGTGCTGCGGAGCTCCCTGGGTCCTCAGCAGTGAGGCTGGCCTCCCTGCGTGACCTGCCCGCCCAGCTCCT GGAGCTGTACCAGCAGGGCTTCTCGCTGGCGGCCCTGCACCCCTTCGTGCAGCCCACCCATGAGCGGGAGAAGACGCCCCTGGAGCACATCTTTAGAGCCATCCTGATCAAGAAAACCGACAGATCTC AGAAAACTGATCTTCACAATGAAGGCTACATCTTGGAATTAGATTGCTGTTCCTCCTTAGACCACCCGACAGACCAGAAACTCATCCCAGAGTTCATTAAGAAGATCCAGGAGGCTGCAAGCCAGGGC CTGAAATTCGTTGGTGTTATACCTCAGTACCATTCCTCTGTGAACTCGGCAGGCAGCAGTGCTCCGGTGTCTACTGCCAACAGCACCGAGGATGCCAGAGATGCAAAAAACGCACGTGGGGATCACGC GTCACTGGAGAATGAGAAACCGGGGACTGGGGATGTGTGCAGTGCTCCGGCTGGGAGAAACCAAAGCCCAGAGCCCAGCTCAGGCCCCAGAGGGGAGGTGCCCCTCGCCAAGCAGCCCAGCTCACCCT CCGGAGAGGGAGATGGTGGAGAACTTTCACCACAGGGGGTGAGCAAGACACTGGATGGACCGGAGAGCAACCCCTTGGAGGTGCATGAAGAGCCACTCTCAGGGAAAATGGAGATCTTCACCCTTTTC AACAAACCGAAGAGCCATCAGAAGTGCCGGCAATACTACCCTGTCACCATTCCTCTCCATGTCTCCAAGAATGGCCAGACAGTGAGCGGTTTGGACGCCAACTGGTTAGAGCACATGAGCGACCACTT CCGGAAAGGAGGCATGCTGGTGAACGCAGTCTTCTACCTTGGAATAGTGAATGATTCCTTACATGGCTTGACAGATGGAGTATTCATCTTTGAAGCTGTTTCCACAGAAGATAGCAAAACCATACAGG GCTATGATGCTATTGTGGTTGAACAATGGACAGTCCTGGAAGGTGTCGAAGTGCAGACAGACTACGTGCCCCTGCTGAACTCGCTGGCGGCCTATGGCTGGCAGCTCACCTGTGTGCTACCAACTCCC GTCGTCAAGACTACCAGCGAGGGGAGTGTATCCACCAAGCAGATTGTCTTTCTTCAGAGACCTTGTCTACCTCAGAAAATCAAGAAGAAGGAATCGAAGTTTCAGTGGCGATTCTCCAGAGAAGAAAT GCACAACAGGCAGATGAGGAAATCAAAAGGTAAACTCAGTGCCAGAGACAAACAACAAGCAGAAGAAAATGAGAAGAACTTAGAAGACCAGTCTTCCAAAGCTGGAGACATGGGAAACTGTGTTTCAG GACAGCAGCAGGAGGGTGGAGTCTCCGAGGAGATGAAGGGCCCTGTCCAAGAGGACAAGGGAGAACAGCTGTCCCCTGGTGGCCTGCTGTGTGGGGTGGGTGTGGAGGGTGAGGCTGTGCAGAATGGT CCTGCCAGCCACAGCAGGGCCCTGGTGGGGATTTGCACTGGGCACTCCAATCCTGGAGAGGATGCCAGGGACGGGGATGCTGAGGAAGTCAGAGAGCTTGGTACGGTTGAAGAAAACTGAGTCTTGGG CAATTTGTGCTAAAACTAGGTGAGTTGCCAAACCCAAGGCATCTTACCAACAGCTGGTTTGGGGGCTGGTTTCCCTGGTGTTGTGTGTTACCTACCCTTTGGCTTGGCTTGACCTCTCCTTGTGAGCT CACCTGAGCCCTCCCAGGGCCAGGTTCCTGACAGTGTTGGTTTTTGCACATCCACTGGAAAGGTGTCATTAATGACCCAGTGTTAGAATGCAAGAGGTCAGGTTATTCTAGCCCTCATGGCTGAAGGC CCAGTCCTGGCTCCACCACTCCTCCAGCCAGAGGGTCTGGACCATCCAGTGCCTGTCCTCGCCACAGGGCCTCCAGGGAGCATTCGGGTCAAATCCATGGACACCCTGGGCTACAAACCAAGGCTGCT GTTCATCCCACATCGTGTGGGGCAGTGTCCATCCCCTGCAGCTACTTGGTGACTTAACAACTCCAGGAGCCCTGTCAGCTGCCCTCCTCCACCTAAACCCCTTCGACTCTTCTGCTTTGACAAAGAAA ATGACATTGGGGAGGGGAGGTGCTCCGCCTCCCAGCTTTTCTCAAAATAGTCCTATAGATACTGGTAATCTGGAAATGAAGAAGTAATTCTGTCTCTGCACCTACTTTTGCAGAATGTTCAAGGAAGT ATTCTGTGTTAGTATTAATGCCAAAAAGTTGTTTTTAAAGGTTTTGTACTCAGCACATCATACAAACCACATTACTTCTGTCACTTCAGGGCATCGGGACTGGCTGGCGCCCTTGTTATGTGCTATTT TAATCAGTGTAACATTGGTCAAGTTGTTACCCATGTATGCTGTGTTTATCATGTGTATATCGTCCAGAAAGTATTAAGGCTTTAGGTAGATGCAACTGGCGAACCTTGGAGAGGGAATGCTGATTGTC TTGACCAAACCCACAGCCTGTCTCTTCTCTTGTTTAGTTACTTACGGCAATAAATCATCTATGAGTTAGTGCACCGTGA
hide sequence
RefSeq Acc Id:
XM_005264986 ⟹ XP_005265043
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 3 16,315,845 - 16,512,916 (-) NCBI GRCh37 3 16,357,352 - 16,555,222 (-) NCBI
Sequence:
GGGGACAGAGGTGCTGGACGTGTAGGAGCAGACATGCCGCGCGCTCCGAGGAAGCGCCGGAACCACCAGAAGCACAGGGACGCGGGTGCCGAGAGTCCCCAGCACTGAAAACGGGGATCTCCTCTTCT CTGCTGAAATGGGTTGCGGATTGAACAAGTTAGAGAAACGTGATGAAAAACGGCCTGGGAATATTTATTCAACTTTGAAGAGGCCTCAGGTGGAAACCAAGATAGATGTGTCCTATGAATACCGCTTC CTGGAGTTCACGACTCTGAGTGCTGCGGAGCTCCCTGGGTCCTCAGCAGTGAGGCTGGCCTCCCTGCGTGACCTGCCCGCCCAGCTCCTGGAGCTGTACCAGCAGGGCTTCTCGCTGGCGGCCCTGCA CCCCTTCGTGCAGCCCACCCATGAGCGGGAGAAGACGCCCCTGGAGCACATCTTTAGAGCCATCCTGATCAAGAAAACCGACAGATCTCAGAAAACTGATCTTCACAATGAAGGCTACATCTTGGAAT TAGATTGCTGTTCCTCCTTAGACCACCCGACAGACCAGAAACTCATCCCAGAGTTCATTAAGAAGATCCAGGAGGCTGCAAGCCAGGGCCTGAAATTCGTTGGTGTTATACCTCAGTACCATTCCTCT GTGAACTCGGCAGGCAGCAGTGCTCCGGTGTCTACTGCCAACAGCACCGAGGATGCCAGAGATGCAAAAAACGCACGTGGGGATCACGCGTCACTGGAGAATGAGAAACCGGGGACTGGGGATGTGTG CAGTGCTCCGGCTGGGAGAAACCAAAGCCCAGAGCCCAGCTCAGGCCCCAGAGGGGAGGTGCCCCTCGCCAAGCAGCCCAGCTCACCCTCCGGAGAGGGAGATGGTGGAGAACTTTCACCACAGGGGG TGAGCAAGACACTGGATGGACCGGAGAGCAACCCCTTGGAGGTGCATGAAGAGCCACTCTCAGGGAAAATGGAGATCTTCACCCTTTTCAACAAACCGAAGAGCCATCAGAAGTGCCGGCAATACTAC CCTGTCACCATTCCTCTCCATGTCTCCAAGAATGGCCAGACAGTGAGCGGTTTGGACGCCAACTGGTTAGAGCACATGAGCGACCACTTCCGGAAAGGAGGCATGCTGGTGAACGCAGTCTTCTACCT TGGAATAGTGAATGATTCCTTACATGGCTTGACAGATGGAGTATTCATCTTTGAAGCTGTTTCCACAGAAGATAGCAAAACCATACAGGGCTATGATGCTATTGTGGTTGAACAATGGACAGTCCTGG AAGGTGTCGAAGTGCAGACAGACTACGTGCCCCTGCTGAACTCGCTGGCGGCCTATGGCTGGCAGCTCACCTGTGTGCTACCAACTCCCGTCGTCAAGACTACCAGCGAGGGGAGTGTATCCACCAAG CAGATTGTCTTTCTTCAGAGACCTTGTCTACCTCAGAAAATCAAGAAGAAGGAATCGAAGTTTCAGTGGCGATTCTCCAGAGAAGAAATGCACAACAGGCAGATGAGGAAATCAAAAGGTAAACTCAG TGCCAGAGACAAACAACAAGCAGAAGAAAATGAGAAGAACTTAGAAGACCAGTCTTCCAAAGCTGGAGACATGGGAAACTGTGTTTCAGGACAGCAGCAGGAGGGTGGAGTCTCCGAGGAGATGAAGG GCCCTGTCCAAGAGGACAAGGGAGAACAGCTGTCCCCTGGTGGCCTGCTGTGTGGGGTGGGTGTGGAGGGTGAGGCTGTGCAGAATGGTCCTGCCAGCCACAGCAGGGCCCTGGTGGGGATTTGCACT GGGCACTCCAATCCTGGAGAGGATGCCAGGGACGGGGATGCTGAGGAAGTCAGAGAGCTTGGTACGGTTGAAGAAAACTGAGTCTTGGGCAATTTGTGCTAAAACTAGGTGAGTTGCCAAACCCAAGG CATCTTACCAACAGCTGGTTTGGGGGCTGGTTTCCCTGGTGTTGTGTGTTACCTACCCTTTGGCTTGGCTTGACCTCTCCTTGTGAGCTCACCTGAGCCCTCCCAGGGCCAGGTTCCTGACAGTGTTG GTTTTTGCACATCCACTGGAAAGGTGTCATTAATGACCCAGTGTTAGAATGCAAGAGGTCAGGTTATTCTAGCCCTCATGGCTGAAGGCCCAGTCCTGGCTCCACCACTCCTCCAGCCAGAGGGTCTG GACCATCCAGTGCCTGTCCTCGCCACAGGGCCTCCAGGGAGCATTCGGGTCAAATCCATGGACACCCTGGGCTACAAACCAAGGCTGCTGTTCATCCCACATCGTGTGGGGCAGTGTCCATCCCCTGC AGCTACTTGGTGACTTAACAACTCCAGGAGCCCTGTCAGCTGCCCTCCTCCACCTAAACCCCTTCGACTCTTCTGCTTTGACAAAGAAAATGACATTGGGGAGGGGAGGTGCTCCGCCTCCCAGCTTT TCTCAAAATAGTCCTATAGATACTGGTAATCTGGAAATGAAGAAGTAATTCTGTCTCTGCACCTACTTTTGCAGAATGTTCAAGGAAGTATTCTGTGTTAGTATTAATGCCAAAAAGTTGTTTTTAAA GGTTTTGTACTCAGCACATCATACAAACCACATTACTTCTGTCACTTCAGGGCATCGGGACTGGCTGGCGCCCTTGTTATGTGCTATTTTAATCAGTGTAACATTGGTCAAGTTGTTACCCATGTATG CTGTGTTTATCATGTGTATATCGTCCAGAAAGTATTAAGGCTTTAGGTAGATGCAACTGGCGAACCTTGGAGAGGGAATGCTGATTGTCTTGACCAAACCCACAGCCTGTCTCTTCTCTTGTTTAGTT ACTTACGGCAATAAATCATCTATGAGTTAGTGCACCGTGA
hide sequence
RefSeq Acc Id:
XM_006713069 ⟹ XP_006713132
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 3 16,315,845 - 16,512,916 (-) NCBI
Sequence:
TGCTCTGGGGACAGAGGTGCTGGACGTGTAGGAGCAGACATGCCGCGCGCTCCGAGGAAGCGCC GGAACCACCAGAAGCACAGGGACGCGGGTGCCGAGAGTCCCCAGCACTGAAAACGGGGATCTCCTCTTCTCAGCTGCTGAAATGGGTTGCGGATTGAACAAGTTAGAGAAACGTGATGAAAAACGGCC TGGGAATATTTATTCAACTTTGAAGAGGCCTCAGGTGGAAACCAAGATAGATGTGTCCTATGAATACCGCTTCCTGGAGTTCACGACTCTGAGTGCTGCGGAGCTCCCTGGGTCCTCAGCAGTGAGGC TGGCCTCCCTGCGTGACCTGCCCGCCCAGCTCCTGGAGCTGTACCAGCAGGGCTTCTCGCTGGCGGCCCTGCACCCCTTCGTGCAGCCCACCCATGAGCGGGAGAAGACGCCCCTGGAGCACATCTTT AGAGCCATCCTGATCAAGAAAACCGACAGATCTCAGAAAACTGATCTTCACAATGAAGGCTACATCTTGGAATTAGATTGCTGTTCCTCCTTAGACCACCCGACAGACCAGAAACTCATCCCAGAGTT CATTAAGAAGATCCAGGAGGCTGCAAGCCAGGGCCTGAAATTCGTTGGTGTTATACCTCAGTACCATTCCTCTGTGAACTCGGCAGGCAGCAGTGCTCCGGTGTCTACTGCCAACAGCACCGAGGATG CCAGAGATGCAAAAAACGCACGTGGGGATCACGCGTCACTGGAGAATGAGAAACCGGGGACTGGGGATGTGTGCAGTGCTCCGGCTGGGAGAAACCAAAGCCCAGAGCCCAGCTCAGGCCCCAGAGGG GAGGTGCCCCTCGCCAAGCAGCCCAGCTCACCCTCCGGAGAGGGAGATGGTGGAGAACTTTCACCACAGGGGGTGAGCAAGACACTGGATGGACCGGAGAGCAACCCCTTGGAGGTGCATGAAGAGCC ACTCTCAGGGAAAATGGAGATCTTCACCCTTTTCAACAAACCGAAGAGCCATCAGAAGTGCCGGCAATACTACCCTGTCACCATTCCTCTCCATGTCTCCAAGAATGGCCAGACAGTGAGCGGTTTGG ACGCCAACTGGTTAGAGCACATGAGCGACCACTTCCGGAAAGGAGGCATGCTGGTGAACGCAGTCTTCTACCTTGGAATAGTGAATGATTCCTTACATGGCTTGACAGATGGAGTATTCATCTTTGAA GCTGTTTCCACAGAAGATAGCAAAACCATACAGGGCTATGATGCTATTGTGGTTGAACAATGGACAGTCCTGGAAGGTGTCGAAGTGCAGACAGACTACGTGCCCCTGCTGAACTCGCTGGCGGCCTA TGGCTGGCAGCTCACCTGTGTGCTACCAACTCCCGTCGTCAAGACTACCAGCGAGGGGAGTGTATCCACCAAGCAGATTGTCTTTCTTCAGAGACCTTGTCTACCTCAGAAAATCAAGAAGAAGGAAT CGAAGTTTCAGTGGCGATTCTCCAGAGAAGAAATGCACAACAGGCAGATGAGGAAATCAAAAGGTAAACTCAGTGCCAGAGACAAACAACAAGCAGAAGAAAATGAGAAGAACTTAGAAGACCAGTCT TCCAAAGCTGGAGACATGGGAAACTGTGTTTCAGGACAGCAGCAGGAGGGTGGAGTCTCCGAGGAGATGAAGGGCCCTGTCCAAGAGGACAAGGGAGAACAGCTGTCCCCTGGTGGCCTGCTGTGTGG GGTGGGTGTGGAGGGTGAGGCTGTGCAGAATGGTCCTGCCAGCCACAGCAGGGCCCTGGTGGGGATTTGCACTGGGCACTCCAATCCTGGAGAGGATGCCAGGGACGGGGATGCTGAGGAAGTCAGAG AGCTTGGTACGGTTGAAGAAAACTGAGTCTTGGGCAATTTGTGCTAAAACTAGGTGAGTTGCCAAACCCAAGGCATCTTACCAACAGCTGGTTTGGGGGCTGGTTTCCCTGGTGTTGTGTGTTACCTA CCCTTTGGCTTGGCTTGACCTCTCCTTGTGAGCTCACCTGAGCCCTCCCAGGGCCAGGTTCCTGACAGTGTTGGTTTTTGCACATCCACTGGAAAGGTGTCATTAATGACCCAGTGTTAGAATGCAAG AGGTCAGGTTATTCTAGCCCTCATGGCTGAAGGCCCAGTCCTGGCTCCACCACTCCTCCAGCCAGAGGGTCTGGACCATCCAGTGCCTGTCCTCGCCACAGGGCCTCCAGGGAGCATTCGGGTCAAAT CCATGGACACCCTGGGCTACAAACCAAGGCTGCTGTTCATCCCACATCGTGTGGGGCAGTGTCCATCCCCTGCAGCTACTTGGTGACTTAACAACTCCAGGAGCCCTGTCAGCTGCCCTCCTCCACCT AAACCCCTTCGACTCTTCTGCTTTGACAAAGAAAATGACATTGGGGAGGGGAGGTGCTCCGCCTCCCAGCTTTTCTCAAAATAGTCCTATAGATACTGGTAATCTGGAAATGAAGAAGTAATTCTGTC TCTGCACCTACTTTTGCAGAATGTTCAAGGAAGTATTCTGTGTTAGTATTAATGCCAAAAAGTTGTTTTTAAAGGTTTTGTACTCAGCACATCATACAAACCACATTACTTCTGTCACTTCAGGGCAT CGGGACTGGCTGGCGCCCTTGTTATGTGCTATTTTAATCAGTGTAACATTGGTCAAGTTGTTACCCATGTATGCTGTGTTTATCATGTGTATATCGTCCAGAAAGTATTAAGGCTTTAGGTAGATGCA ACTGGCGAACCTTGGAGAGGGAATGCTGATTGTCTTGACCAAACCCACAGCCTGTCTCTTCTCTTGTTTAGTTACTTACGGCAATAAATCATCTATGAGTTAGTGCACCGTGA
hide sequence
RefSeq Acc Id:
XM_011533530 ⟹ XP_011531832
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 3 16,315,845 - 16,513,522 (-) NCBI
Sequence:
CCGGGTCTCTGGCGGGTAGTGGGAACCGCGCGTGGCGCCTCCCTGCAGGTTGCTCTTTGCCGGGGCTCCGGAGCTGCCAGAGCAGCACCCCCTGGCCCGCGTCGGATGGGGACCTGGGCTGATCCTTG GGACGCCTGGATCTTGGGCCAACTTTTTTTTGCGGGGAACGGGTGTAGGGGAGTCATTCCTGGAGCGATGTAGGGAGAGGCACTTCGGAGCAGCCTGTTGGGGGTCGTAGGCTCTGCAGGCTCAGAAG CGCCTAGGAAGGACGCAGAGGTGGGGGAGCTTGGAGGCTACAGCTGCTGAAATGGGTTGCGGATTGAACAAGTTAGAGAAACGTGATGAAAAACGGCCTGGGAATATTTATTCAACTTTGAAGAGGCC TCAGGTGGAAACCAAGATAGATGTGTCCTATGAATACCGCTTCCTGGAGTTCACGACTCTGAGTGCTGCGGAGCTCCCTGGGTCCTCAGCAGTGAGGCTGGCCTCCCTGCGTGACCTGCCCGCCCAGC TCCTGGAGCTGTACCAGCAGGGCTTCTCGCTGGCGGCCCTGCACCCCTTCGTGCAGCCCACCCATGAGCGGGAGAAGACGCCCCTGGAGCACATCTTTAGAGCCATCCTGATCAAGAAAACCGACAGA TCTCAGAAAACTGATCTTCACAATGAAGGCTACATCTTGGAATTAGATTGCTGTTCCTCCTTAGACCACCCGACAGACCAGAAACTCATCCCAGAGTTCATTAAGAAGATCCAGGAGGCTGCAAGCCA GGGCCTGAAATTCGTTGGTGTTATACCTCAGTACCATTCCTCTGTGAACTCGGCAGGCAGCAGTGCTCCGGTGTCTACTGCCAACAGCACCGAGGATGCCAGAGATGCAAAAAACGCACGTGGGGATC ACGCGTCACTGGAGAATGAGAAACCGGGGACTGGGGATGTGTGCAGTGCTCCGGCTGGGAGAAACCAAAGCCCAGAGCCCAGCTCAGGCCCCAGAGGGGAGGTGCCCCTCGCCAAGCAGCCCAGCTCA CCCTCCGGAGAGGGAGATGGTGGAGAACTTTCACCACAGGGGGTGAGCAAGACACTGGATGGACCGGAGAGCAACCCCTTGGAGGTGCATGAAGAGCCACTCTCAGGGAAAATGGAGATCTTCACCCT TTTCAACAAACCGAAGAGCCATCAGAAGTGCCGGCAATACTACCCTGTCACCATTCCTCTCCATGTCTCCAAGAATGGCCAGACAGTGAGCGGTTTGGACGCCAACTGGTTAGAGCACATGAGCGACC ACTTCCGGAAAGGAGGCATGCTGGTGAACGCAGTCTTCTACCTTGGAATAGTGAATGATTCCTTACATGGCTTGACAGATGGAGTATTCATCTTTGAAGCTGTTTCCACAGAAGATAGCAAAACCATA CAGGGCTATGATGCTATTGTGGTTGAACAATGGACAGTCCTGGAAGGTGTCGAAGTGCAGACAGACTACGTGCCCCTGCTGAACTCGCTGGCGGCCTATGGCTGGCAGCTCACCTGTGTGCTACCAAC TCCCGTCGTCAAGACTACCAGCGAGGGGAGTGTATCCACCAAGCAGATTGTCTTTCTTCAGAGACCTTGTCTACCTCAGAAAATCAAGAAGAAGGAATCGAAGTTTCAGTGGCGATTCTCCAGAGAAG AAATGCACAACAGGCAGATGAGGAAATCAAAAGGTAAACTCAGTGCCAGAGACAAACAACAAGCAGAAGAAAATGAGAAGAACTTAGAAGACCAGTCTTCCAAAGCTGGAGACATGGGAAACTGTGTT TCAGGACAGCAGCAGGAGGGTGGAGTCTCCGAGGAGATGAAGGGCCCTGTCCAAGAGGACAAGGGAGAACAGCTGTCCCCTGGTGGCCTGCTGTGTGGGGTGGGTGTGGAGGGTGAGGCTGTGCAGAA TGGTCCTGCCAGCCACAGCAGGGCCCTGGTGGGGATTTGCACTGGGCACTCCAATCCTGGAGAGGATGCCAGGGACGGGGATGCTGAGGAAGTCAGAGAGCTTGGTACGGTTGAAGAAAACTGAGTCT TGGGCAATTTGTGCTAAAACTAGGTGAGTTGCCAAACCCAAGGCATCTTACCAACAGCTGGTTTGGGGGCTGGTTTCCCTGGTGTTGTGTGTTACCTACCCTTTGGCTTGGCTTGACCTCTCCTTGTG AGCTCACCTGAGCCCTCCCAGGGCCAGGTTCCTGACAGTGTTGGTTTTTGCACATCCACTGGAAAGGTGTCATTAATGACCCAGTGTTAGAATGCAAGAGGTCAGGTTATTCTAGCCCTCATGGCTGA AGGCCCAGTCCTGGCTCCACCACTCCTCCAGCCAGAGGGTCTGGACCATCCAGTGCCTGTCCTCGCCACAGGGCCTCCAGGGAGCATTCGGGTCAAATCCATGGACACCCTGGGCTACAAACCAAGGC TGCTGTTCATCCCACATCGTGTGGGGCAGTGTCCATCCCCTGCAGCTACTTGGTGACTTAACAACTCCAGGAGCCCTGTCAGCTGCCCTCCTCCACCTAAACCCCTTCGACTCTTCTGCTTTGACAAA GAAAATGACATTGGGGAGGGGAGGTGCTCCGCCTCCCAGCTTTTCTCAAAATAGTCCTATAGATACTGGTAATCTGGAAATGAAGAAGTAATTCTGTCTCTGCACCTACTTTTGCAGAATGTTCAAGG AAGTATTCTGTGTTAGTATTAATGCCAAAAAGTTGTTTTTAAAGGTTTTGTACTCAGCACATCATACAAACCACATTACTTCTGTCACTTCAGGGCATCGGGACTGGCTGGCGCCCTTGTTATGTGCT ATTTTAATCAGTGTAACATTGGTCAAGTTGTTACCCATGTATGCTGTGTTTATCATGTGTATATCGTCCAGAAAGTATTAAGGCTTTAGGTAGATGCAACTGGCGAACCTTGGAGAGGGAATGCTGAT TGTCTTGACCAAACCCACAGCCTGTCTCTTCTCTTGTTTAGTTACTTACGGCAATAAATCATCTATGAGTTAGTGCACCGTGA
hide sequence
RefSeq Acc Id:
XM_017006007 ⟹ XP_016861496
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 3 16,315,845 - 16,513,699 (-) NCBI
Sequence:
AGCGCGCCGGGCGCTGGGCGCAGCGAGCGAGAGCGCGGCGGCCGCGGGCTCCGGCGAGGGACAGACGCACCGATCGCCGGAGGGACAGACACACGACCACGCGGCGCCACCGCCCACGCCTCCACCCA CCGGCGCCCAAGTCCTCCCCGCGCCGCCTCCTCTGTATGGCACAAACTTTCCTCCCGGGACGGAACACGCTGCCTCAGGGAGCCCGCGACCGCGCCTTCTCCTCCGCCGGTCCCATACGCTGCTGAAA TGGGTTGCGGATTGAACAAGTTAGAGAAACGTGATGAAAAACGGCCTGGGAATATTTATTCAACTTTGAAGAGGCCTCAGGTGGAAACCAAGATAGATGTGTCCTATGAATACCGCTTCCTGGAGTTC ACGACTCTGAGTGCTGCGGAGCTCCCTGGGTCCTCAGCAGTGAGGCTGGCCTCCCTGCGTGACCTGCCCGCCCAGCTCCTGGAGCTGTACCAGCAGGGCTTCTCGCTGGCGGCCCTGCACCCCTTCGT GCAGCCCACCCATGAGCGGGAGAAGACGCCCCTGGAGCACATCTTTAGAGCCATCCTGATCAAGAAAACCGACAGATCTCAGAAAACTGATCTTCACAATGAAGGCTACATCTTGGAATTAGATTGCT GTTCCTCCTTAGACCACCCGACAGACCAGAAACTCATCCCAGAGTTCATTAAGAAGATCCAGGAGGCTGCAAGCCAGGGCCTGAAATTCGTTGGTGTTATACCTCAGTACCATTCCTCTGTGAACTCG GCAGGCAGCAGTGCTCCGGTGTCTACTGCCAACAGCACCGAGGATGCCAGAGATGCAAAAAACGCACGTGGGGATCACGCGTCACTGGAGAATGAGAAACCGGGGACTGGGGATGTGTGCAGTGCTCC GGCTGGGAGAAACCAAAGCCCAGAGCCCAGCTCAGGCCCCAGAGGGGAGGTGCCCCTCGCCAAGCAGCCCAGCTCACCCTCCGGAGAGGGAGATGGTGGAGAACTTTCACCACAGGGGGTGAGCAAGA CACTGGATGGACCGGAGAGCAACCCCTTGGAGGTGCATGAAGAGCCACTCTCAGGGAAAATGGAGATCTTCACCCTTTTCAACAAACCGAAGAGCCATCAGAAGTGCCGGCAATACTACCCTGTCACC ATTCCTCTCCATGTCTCCAAGAATGGCCAGACAGTGAGCGGTTTGGACGCCAACTGGTTAGAGCACATGAGCGACCACTTCCGGAAAGGAGGCATGCTGGTGAACGCAGTCTTCTACCTTGGAATAGT GAATGGGTGTCGAAGTGCAGACAGACTACGTGCCCCTGCTGAACTCGCTGGCGGCCTATGGCTGGCAGCTCACCTGTGTGCTACCAACTCCCGTCGTCAAGACTACCAGCGAGGGGAGTGTATCCACC AAGCAGATTGTCTTTCTTCAGAGACCTTGTCTACCTCAGAAAATCAAGAAGAAGGAATCGAAGTTTCAGTGGCGATTCTCCAGAGAAGAAATGCACAACAGGCAGATGAGGAAATCAAAAGGTAAACT CAGTGCCAGAGACAAACAACAAGCAGAAGAAAATGAGAAGAACTTAGAAGACCAGTCTTCCAAAGCTGGAGACATGGGAAACTGTGTTTCAGGACAGCAGCAGGAGGGTGGAGTCTCCGAGGAGATGA AGGGCCCTGTCCAAGAGGACAAGGGAGAACAGCTGTCCCCTGGTGGCCTGCTGTGTGGGGTGGGTGTGGAGGGTGAGGCTGTGCAGAATGGTCCTGCCAGCCACAGCAGGGCCCTGGTGGGGATTTGC ACTGGGCACTCCAATCCTGGAGAGGATGCCAGGGACGGGGATGCTGAGGAAGTCAGAGAGCTTGGTACGGTTGAAGAAAACTGAGTCTTGGGCAATTTGTGCTAAAACTAGGTGAGTTGCCAAACCCA AGGCATCTTACCAACAGCTGGTTTGGGGGCTGGTTTCCCTGGTGTTGTGTGTTACCTACCCTTTGGCTTGGCTTGACCTCTCCTTGTGAGCTCACCTGAGCCCTCCCAGGGCCAGGTTCCTGACAGTG TTGGTTTTTGCACATCCACTGGAAAGGTGTCATTAATGACCCAGTGTTAGAATGCAAGAGGTCAGGTTATTCTAGCCCTCATGGCTGAAGGCCCAGTCCTGGCTCCACCACTCCTCCAGCCAGAGGGT CTGGACCATCCAGTGCCTGTCCTCGCCACAGGGCCTCCAGGGAGCATTCGGGTCAAATCCATGGACACCCTGGGCTACAAACCAAGGCTGCTGTTCATCCCACATCGTGTGGGGCAGTGTCCATCCCC TGCAGCTACTTGGTGACTTAACAACTCCAGGAGCCCTGTCAGCTGCCCTCCTCCACCTAAACCCCTTCGACTCTTCTGCTTTGACAAAGAAAATGACATTGGGGAGGGGAGGTGCTCCGCCTCCCAGC TTTTCTCAAAATAGTCCTATAGATACTGGTAATCTGGAAATGAAGAAGTAATTCTGTCTCTGCACCTACTTTTGCAGAATGTTCAAGGAAGTATTCTGTGTTAGTATTAATGCCAAAAAGTTGTTTTT AAAGGTTTTGTACTCAGCACATCATACAAACCACATTACTTCTGTCACTTCAGGGCATCGGGACTGGCTGGCGCCCTTGTTATGTGCTATTTTAATCAGTGTAACATTGGTCAAGTTGTTACCCATGT ATGCTGTGTTTATCATGTGTATATCGTCCAGAAAGTATTAAGGCTTTAGGTAGATGCAACTGGCGAACCTTGGAGAGGGAATGCTGATTGTCTTGACCAAACCCACAGCCTGTCTCTTCTCTTGTTTA GTTACTTACGGCAATAAATCATCTATGAGTTAGTGCACCGTGA
hide sequence
RefSeq Acc Id:
XM_047447779 ⟹ XP_047303735
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 3 16,315,845 - 16,472,794 (-) NCBI
RefSeq Acc Id:
XM_047447780 ⟹ XP_047303736
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 3 16,315,845 - 16,513,522 (-) NCBI
RefSeq Acc Id:
XM_047447781 ⟹ XP_047303737
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 3 16,315,845 - 16,472,799 (-) NCBI
RefSeq Acc Id:
XM_047447783 ⟹ XP_047303739
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 3 16,315,845 - 16,513,699 (-) NCBI
RefSeq Acc Id:
XM_054345823 ⟹ XP_054201798
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 3 16,317,057 - 16,473,932 (-) NCBI
RefSeq Acc Id:
XM_054345824 ⟹ XP_054201799
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 3 16,317,057 - 16,514,836 (-) NCBI
RefSeq Acc Id:
XM_054345825 ⟹ XP_054201800
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 3 16,317,057 - 16,514,044 (-) NCBI
RefSeq Acc Id:
XM_054345826 ⟹ XP_054201801
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 3 16,317,057 - 16,514,044 (-) NCBI
RefSeq Acc Id:
XM_054345827 ⟹ XP_054201802
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 3 16,317,057 - 16,514,347 (-) NCBI
RefSeq Acc Id:
XM_054345828 ⟹ XP_054201803
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 3 16,317,057 - 16,473,937 (-) NCBI
RefSeq Acc Id:
XM_054345829 ⟹ XP_054201804
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 3 16,317,057 - 16,514,836 (-) NCBI
RefSeq Acc Id:
XM_054345830 ⟹ XP_054201805
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 3 16,317,057 - 16,514,836 (-) NCBI
RefSeq Acc Id:
NP_055965 ⟸ NM_015150
- UniProtKB:
Q5JB48 (UniProtKB/Swiss-Prot), Q4QQI7 (UniProtKB/Swiss-Prot), Q496Y2 (UniProtKB/Swiss-Prot), Q0D2G0 (UniProtKB/Swiss-Prot), Q7Z7P2 (UniProtKB/Swiss-Prot), Q14699 (UniProtKB/Swiss-Prot), G3XAJ6 (UniProtKB/TrEMBL)
- Sequence:
MGCGLNKLEKRDEKRPGNIYSTLKRPQVETKIDVSYEYRFLEFTTLSAAELPGSSAVRLASLRDLPAQLLELYQQGFSLAALHPFVQPTHEREKTPLEHIFRAILIKKTDRSQKTDLHNEGYILELDC CSSLDHPTDQKLIPEFIKKIQEAASQGLKFVGVIPQYHSSVNSAGSSAPVSTANSTEDARDAKNARGDHASLENEKPGTGDVCSAPAGRNQSPEPSSGPRGEVPLAKQPSSPSGEGDGGELSPQGVSK TLDGPESNPLEVHEEPLSGKMEIFTLFNKPKSHQKCRQYYPVTIPLHVSKNGQTVSGLDANWLEHMSDHFRKGGMLVNAVFYLGIVNDSLHGLTDGVFIFEAVSTEDSKTIQGYDAIVVEQWTVLEGV EVQTDYVPLLNSLAAYGWQLTCVLPTPVVKTTSEGSVSTKQIVFLQRPCLPQKIKKKESKFQWRFSREEMHNRQMRKSKGKLSARDKQQAEENEKNLEDQSSKAGDMGNCVSGQQQEGGVSEEMKGPV QEDKGEQLSPGGLLCGVGVEGEAVQNGPASHSRALVGICTGHSNPGEDARDGDAEEVRELGTVEEN
hide sequence
RefSeq Acc Id:
XP_005265042 ⟸ XM_005264985
- Peptide Label:
isoform X2
- UniProtKB:
Q5JB48 (UniProtKB/Swiss-Prot), Q4QQI7 (UniProtKB/Swiss-Prot), Q496Y2 (UniProtKB/Swiss-Prot), Q0D2G0 (UniProtKB/Swiss-Prot), Q7Z7P2 (UniProtKB/Swiss-Prot), Q14699 (UniProtKB/Swiss-Prot), G3XAJ6 (UniProtKB/TrEMBL)
- Sequence:
MGCGLNKLEKRDEKRPGNIYSTLKRPQVETKIDVSYEYRFLEFTTLSAAELPGSSAVRLASLRDLPAQLLELYQQGFSLAALHPFVQPTHEREKTPLEHIFRAILIKKTDRSQKTDLHNEGYILELDC CSSLDHPTDQKLIPEFIKKIQEAASQGLKFVGVIPQYHSSVNSAGSSAPVSTANSTEDARDAKNARGDHASLENEKPGTGDVCSAPAGRNQSPEPSSGPRGEVPLAKQPSSPSGEGDGGELSPQGVSK TLDGPESNPLEVHEEPLSGKMEIFTLFNKPKSHQKCRQYYPVTIPLHVSKNGQTVSGLDANWLEHMSDHFRKGGMLVNAVFYLGIVNDSLHGLTDGVFIFEAVSTEDSKTIQGYDAIVVEQWTVLEGV EVQTDYVPLLNSLAAYGWQLTCVLPTPVVKTTSEGSVSTKQIVFLQRPCLPQKIKKKESKFQWRFSREEMHNRQMRKSKGKLSARDKQQAEENEKNLEDQSSKAGDMGNCVSGQQQEGGVSEEMKGPV QEDKGEQLSPGGLLCGVGVEGEAVQNGPASHSRALVGICTGHSNPGEDARDGDAEEVRELGTVEEN
hide sequence
RefSeq Acc Id:
XP_005265043 ⟸ XM_005264986
- Peptide Label:
isoform X2
- UniProtKB:
Q5JB48 (UniProtKB/Swiss-Prot), Q4QQI7 (UniProtKB/Swiss-Prot), Q496Y2 (UniProtKB/Swiss-Prot), Q0D2G0 (UniProtKB/Swiss-Prot), Q7Z7P2 (UniProtKB/Swiss-Prot), Q14699 (UniProtKB/Swiss-Prot), G3XAJ6 (UniProtKB/TrEMBL)
- Sequence:
MGCGLNKLEKRDEKRPGNIYSTLKRPQVETKIDVSYEYRFLEFTTLSAAELPGSSAVRLASLRDLPAQLLELYQQGFSLAALHPFVQPTHEREKTPLEHIFRAILIKKTDRSQKTDLHNEGYILELDC CSSLDHPTDQKLIPEFIKKIQEAASQGLKFVGVIPQYHSSVNSAGSSAPVSTANSTEDARDAKNARGDHASLENEKPGTGDVCSAPAGRNQSPEPSSGPRGEVPLAKQPSSPSGEGDGGELSPQGVSK TLDGPESNPLEVHEEPLSGKMEIFTLFNKPKSHQKCRQYYPVTIPLHVSKNGQTVSGLDANWLEHMSDHFRKGGMLVNAVFYLGIVNDSLHGLTDGVFIFEAVSTEDSKTIQGYDAIVVEQWTVLEGV EVQTDYVPLLNSLAAYGWQLTCVLPTPVVKTTSEGSVSTKQIVFLQRPCLPQKIKKKESKFQWRFSREEMHNRQMRKSKGKLSARDKQQAEENEKNLEDQSSKAGDMGNCVSGQQQEGGVSEEMKGPV QEDKGEQLSPGGLLCGVGVEGEAVQNGPASHSRALVGICTGHSNPGEDARDGDAEEVRELGTVEEN
hide sequence
RefSeq Acc Id:
XP_006713132 ⟸ XM_006713069
- Peptide Label:
isoform X2
- UniProtKB:
Q5JB48 (UniProtKB/Swiss-Prot), Q4QQI7 (UniProtKB/Swiss-Prot), Q496Y2 (UniProtKB/Swiss-Prot), Q0D2G0 (UniProtKB/Swiss-Prot), Q7Z7P2 (UniProtKB/Swiss-Prot), Q14699 (UniProtKB/Swiss-Prot), G3XAJ6 (UniProtKB/TrEMBL)
- Sequence:
MGCGLNKLEKRDEKRPGNIYSTLKRPQVETKIDVSYEYRFLEFTTLSAAELPGSSAVRLASLRDLPAQLLELYQQGFSLAALHPFVQPTHEREKTPLEHIFRAILIKKTDRSQKTDLHNEGYILELDC CSSLDHPTDQKLIPEFIKKIQEAASQGLKFVGVIPQYHSSVNSAGSSAPVSTANSTEDARDAKNARGDHASLENEKPGTGDVCSAPAGRNQSPEPSSGPRGEVPLAKQPSSPSGEGDGGELSPQGVSK TLDGPESNPLEVHEEPLSGKMEIFTLFNKPKSHQKCRQYYPVTIPLHVSKNGQTVSGLDANWLEHMSDHFRKGGMLVNAVFYLGIVNDSLHGLTDGVFIFEAVSTEDSKTIQGYDAIVVEQWTVLEGV EVQTDYVPLLNSLAAYGWQLTCVLPTPVVKTTSEGSVSTKQIVFLQRPCLPQKIKKKESKFQWRFSREEMHNRQMRKSKGKLSARDKQQAEENEKNLEDQSSKAGDMGNCVSGQQQEGGVSEEMKGPV QEDKGEQLSPGGLLCGVGVEGEAVQNGPASHSRALVGICTGHSNPGEDARDGDAEEVRELGTVEEN
hide sequence
RefSeq Acc Id:
XP_011531832 ⟸ XM_011533530
- Peptide Label:
isoform X2
- UniProtKB:
Q5JB48 (UniProtKB/Swiss-Prot), Q4QQI7 (UniProtKB/Swiss-Prot), Q496Y2 (UniProtKB/Swiss-Prot), Q0D2G0 (UniProtKB/Swiss-Prot), Q7Z7P2 (UniProtKB/Swiss-Prot), Q14699 (UniProtKB/Swiss-Prot), G3XAJ6 (UniProtKB/TrEMBL)
- Sequence:
MGCGLNKLEKRDEKRPGNIYSTLKRPQVETKIDVSYEYRFLEFTTLSAAELPGSSAVRLASLRDLPAQLLELYQQGFSLAALHPFVQPTHEREKTPLEHIFRAILIKKTDRSQKTDLHNEGYILELDC CSSLDHPTDQKLIPEFIKKIQEAASQGLKFVGVIPQYHSSVNSAGSSAPVSTANSTEDARDAKNARGDHASLENEKPGTGDVCSAPAGRNQSPEPSSGPRGEVPLAKQPSSPSGEGDGGELSPQGVSK TLDGPESNPLEVHEEPLSGKMEIFTLFNKPKSHQKCRQYYPVTIPLHVSKNGQTVSGLDANWLEHMSDHFRKGGMLVNAVFYLGIVNDSLHGLTDGVFIFEAVSTEDSKTIQGYDAIVVEQWTVLEGV EVQTDYVPLLNSLAAYGWQLTCVLPTPVVKTTSEGSVSTKQIVFLQRPCLPQKIKKKESKFQWRFSREEMHNRQMRKSKGKLSARDKQQAEENEKNLEDQSSKAGDMGNCVSGQQQEGGVSEEMKGPV QEDKGEQLSPGGLLCGVGVEGEAVQNGPASHSRALVGICTGHSNPGEDARDGDAEEVRELGTVEEN
hide sequence
RefSeq Acc Id:
XP_016861496 ⟸ XM_017006007
- Peptide Label:
isoform X4
- Sequence:
MGCGLNKLEKRDEKRPGNIYSTLKRPQVETKIDVSYEYRFLEFTTLSAAELPGSSAVRLASLRDLPAQLLELYQQGFSLAALHPFVQPTHEREKTPLEHIFRAILIKKTDRSQKTDLHNEGYILELDC CSSLDHPTDQKLIPEFIKKIQEAASQGLKFVGVIPQYHSSVNSAGSSAPVSTANSTEDARDAKNARGDHASLENEKPGTGDVCSAPAGRNQSPEPSSGPRGEVPLAKQPSSPSGEGDGGELSPQGVSK TLDGPESNPLEVHEEPLSGKMEIFTLFNKPKSHQKCRQYYPVTIPLHVSKNGQTVSGLDANWLEHMSDHFRKGGMLVNAVFYLGIVNGCRSADRLRAPAELAGGLWLAAHLCATNSRRQDYQRGECIH QADCLSSETLSTSENQEEGIEVSVAILQRRNAQQADEEIKR
hide sequence
Ensembl Acc Id:
ENSP00000403997 ⟸ ENST00000451036
Ensembl Acc Id:
ENSP00000334153 ⟸ ENST00000334133
Ensembl Acc Id:
ENSP00000410493 ⟸ ENST00000453536
Ensembl Acc Id:
ENSP00000388718 ⟸ ENST00000441460
Ensembl Acc Id:
ENSP00000393216 ⟸ ENST00000431547
Ensembl Acc Id:
ENSP00000403926 ⟸ ENST00000432519
Ensembl Acc Id:
ENSP00000409427 ⟸ ENST00000449415
Ensembl Acc Id:
ENSP00000475367 ⟸ ENST00000607320
RefSeq Acc Id:
XP_047303739 ⟸ XM_047447783
- Peptide Label:
isoform X4
RefSeq Acc Id:
XP_047303736 ⟸ XM_047447780
- Peptide Label:
isoform X2
- UniProtKB:
Q5JB48 (UniProtKB/Swiss-Prot), Q4QQI7 (UniProtKB/Swiss-Prot), Q496Y2 (UniProtKB/Swiss-Prot), Q14699 (UniProtKB/Swiss-Prot), Q0D2G0 (UniProtKB/Swiss-Prot), Q7Z7P2 (UniProtKB/Swiss-Prot), G3XAJ6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_047303737 ⟸ XM_047447781
- Peptide Label:
isoform X3
RefSeq Acc Id:
XP_047303735 ⟸ XM_047447779
- Peptide Label:
isoform X1
- UniProtKB:
G3XAJ6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_054201804 ⟸ XM_054345829
- Peptide Label:
isoform X4
RefSeq Acc Id:
XP_054201805 ⟸ XM_054345830
- Peptide Label:
isoform X4
RefSeq Acc Id:
XP_054201799 ⟸ XM_054345824
- Peptide Label:
isoform X2
- UniProtKB:
Q5JB48 (UniProtKB/Swiss-Prot), Q4QQI7 (UniProtKB/Swiss-Prot), Q496Y2 (UniProtKB/Swiss-Prot), Q14699 (UniProtKB/Swiss-Prot), Q0D2G0 (UniProtKB/Swiss-Prot), Q7Z7P2 (UniProtKB/Swiss-Prot), G3XAJ6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_054201802 ⟸ XM_054345827
- Peptide Label:
isoform X2
- UniProtKB:
Q5JB48 (UniProtKB/Swiss-Prot), Q4QQI7 (UniProtKB/Swiss-Prot), Q496Y2 (UniProtKB/Swiss-Prot), Q14699 (UniProtKB/Swiss-Prot), Q0D2G0 (UniProtKB/Swiss-Prot), Q7Z7P2 (UniProtKB/Swiss-Prot), G3XAJ6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_054201801 ⟸ XM_054345826
- Peptide Label:
isoform X2
- UniProtKB:
Q5JB48 (UniProtKB/Swiss-Prot), Q4QQI7 (UniProtKB/Swiss-Prot), Q496Y2 (UniProtKB/Swiss-Prot), Q14699 (UniProtKB/Swiss-Prot), Q0D2G0 (UniProtKB/Swiss-Prot), Q7Z7P2 (UniProtKB/Swiss-Prot), G3XAJ6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_054201800 ⟸ XM_054345825
- Peptide Label:
isoform X2
- UniProtKB:
Q5JB48 (UniProtKB/Swiss-Prot), Q4QQI7 (UniProtKB/Swiss-Prot), Q496Y2 (UniProtKB/Swiss-Prot), Q14699 (UniProtKB/Swiss-Prot), Q0D2G0 (UniProtKB/Swiss-Prot), Q7Z7P2 (UniProtKB/Swiss-Prot), G3XAJ6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_054201803 ⟸ XM_054345828
- Peptide Label:
isoform X3
RefSeq Acc Id:
XP_054201798 ⟸ XM_054345823
- Peptide Label:
isoform X1
- UniProtKB:
G3XAJ6 (UniProtKB/TrEMBL)
RGD ID: 6812380
Promoter ID: HG_ACW:53063
Type: Non-CpG
SO ACC ID: SO:0000170
Source: MPROMDB
Tissues & Cell Lines: K562
Transcripts: RFTN1.NAPR07-UNSPLICED
Position: Human Assembly Chr Position (strand) Source Build 36 3 16,330,036 - 16,330,536 (-) MPROMDB
RGD ID: 6801523
Promoter ID: HG_KWN:43963
Type: Non-CpG
SO ACC ID: SO:0000170
Source: MPROMDB
Tissues & Cell Lines: Lymphoblastoid
Transcripts: OTTHUMT00000346910
Position: Human Assembly Chr Position (strand) Source Build 36 3 16,387,216 - 16,388,382 (-) MPROMDB
RGD ID: 6863724
Promoter ID: EPDNEW_H5027
Type: multiple initiation site
Name: RFTN1_3
Description: raftlin, lipid raft linker 1
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_H5028 EPDNEW_H5029
Experiment Methods: Single-end sequencing.
Position: Human Assembly Chr Position (strand) Source GRCh38 3 16,482,862 - 16,482,922 EPDNEW
RGD ID: 6801527
Promoter ID: HG_KWN:43965
Type: Non-CpG
SO ACC ID: SO:0000170
Source: MPROMDB
Tissues & Cell Lines: Lymphoblastoid
Transcripts: OTTHUMT00000347266
Position: Human Assembly Chr Position (strand) Source Build 36 3 16,489,041 - 16,489,687 (-) MPROMDB
RGD ID: 6801525
Promoter ID: HG_KWN:43966
Type: Non-CpG
SO ACC ID: SO:0000170
Source: MPROMDB
Tissues & Cell Lines: K562, Lymphoblastoid
Transcripts: OTTHUMT00000346909
Position: Human Assembly Chr Position (strand) Source Build 36 3 16,499,246 - 16,500,087 (-) MPROMDB
RGD ID: 6801528
Promoter ID: HG_KWN:43967
Type: Non-CpG
SO ACC ID: SO:0000170
Source: MPROMDB
Tissues & Cell Lines: Lymphoblastoid
Transcripts: OTTHUMT00000346911
Position: Human Assembly Chr Position (strand) Source Build 36 3 16,500,941 - 16,502,187 (-) MPROMDB
RGD ID: 6863726
Promoter ID: EPDNEW_H5028
Type: initiation region
Name: RFTN1_2
Description: raftlin, lipid raft linker 1
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_H5027 EPDNEW_H5029
Experiment Methods: Single-end sequencing.
Position: Human Assembly Chr Position (strand) Source GRCh38 3 16,513,519 - 16,513,579 EPDNEW
RGD ID: 6863728
Promoter ID: EPDNEW_H5029
Type: initiation region
Name: RFTN1_1
Description: raftlin, lipid raft linker 1
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_H5027 EPDNEW_H5028
Experiment Methods: Single-end sequencing.
Position: Human Assembly Chr Position (strand) Source GRCh38 3 16,513,699 - 16,513,759 EPDNEW
RGD ID: 6801526
Promoter ID: HG_KWN:43968
Type: CpG-Island
SO ACC ID: SO:0000170
Source: MPROMDB
Tissues & Cell Lines: CD4+TCell, CD4+TCell_2Hour, K562, Lymphoblastoid, NB4
Transcripts: NM_015150, OTTHUMT00000346912, OTTHUMT00000346913, OTTHUMT00000347263, OTTHUMT00000347264, OTTHUMT00000347265
Position: Human Assembly Chr Position (strand) Source Build 36 3 16,529,956 - 16,531,532 (-) MPROMDB